Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES GLENMARK PHARMA ZIM LABORATORIES/
GLENMARK PHARMA
 
P/E (TTM) x 28.4 -31.4 - View Chart
P/BV x 2.3 2.9 81.3% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 ZIM LABORATORIES   GLENMARK PHARMA
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-23
GLENMARK PHARMA
Mar-23
ZIM LABORATORIES/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs388487 79.6%   
Low Rs67349 19.3%   
Sales per share (Unadj.) Rs81.8460.4 17.8%  
Earnings per share (Unadj.) Rs5.013.4 37.5%  
Cash flow per share (Unadj.) Rs8.635.0 24.5%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs41.1335.1 12.3%  
Shares outstanding (eoy) m48.73282.17 17.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.80.9 306.6%   
Avg P/E ratio x45.431.3 145.3%  
P/CF ratio (eoy) x26.511.9 222.0%  
Price / Book Value ratio x5.51.2 444.0%  
Dividend payout %018.7 0.0%   
Avg Mkt Cap Rs m11,096117,953 9.4%   
No. of employees `000NANA-   
Total wages/salary Rs m49327,810 1.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m3,985129,901 3.1%  
Other income Rs m643,168 2.0%   
Total revenues Rs m4,049133,069 3.0%   
Gross profit Rs m52015,125 3.4%  
Depreciation Rs m1756,113 2.9%   
Interest Rs m563,496 1.6%   
Profit before tax Rs m3548,685 4.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1094,911 2.2%   
Profit after tax Rs m2443,774 6.5%  
Gross profit margin %13.011.6 112.0%  
Effective tax rate %30.956.5 54.6%   
Net profit margin %6.12.9 211.0%  
BALANCE SHEET DATA
Current assets Rs m1,90998,737 1.9%   
Current liabilities Rs m1,10850,455 2.2%   
Net working cap to sales %20.137.2 54.1%  
Current ratio x1.72.0 88.1%  
Inventory Days Days197 290.8%  
Debtors Days Days872115 757.5%  
Net fixed assets Rs m1,56976,920 2.0%   
Share capital Rs m487282 172.7%   
"Free" reserves Rs m1,51694,281 1.6%   
Net worth Rs m2,00394,563 2.1%   
Long term debt Rs m24638,521 0.6%   
Total assets Rs m3,479175,658 2.0%  
Interest coverage x7.33.5 210.7%   
Debt to equity ratio x0.10.4 30.2%  
Sales to assets ratio x1.10.7 154.9%   
Return on assets %8.64.1 208.4%  
Return on equity %12.24.0 305.6%  
Return on capital %18.29.2 198.8%  
Exports to sales %81.10-   
Imports to sales %12.20-   
Exports (fob) Rs m3,230NA-   
Imports (cif) Rs m485NA-   
Fx inflow Rs m3,28146,464 7.1%   
Fx outflow Rs m48512,712 3.8%   
Net fx Rs m2,79633,751 8.3%   
CASH FLOW
From Operations Rs m3756,254 6.0%  
From Investments Rs m-362-5,285 6.9%  
From Financial Activity Rs m5-775 -0.7%  
Net Cashflow Rs m30325 9.2%  

Share Holding

Indian Promoters % 33.3 46.7 71.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 34.7 -  
FIIs % 0.0 23.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 53.4 125.1%  
Shareholders   17,342 209,931 8.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ZIM LABORATORIES vs Glenmark Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ZIM LABORATORIES vs Glenmark Pharma Share Price Performance

Period ZIM LABORATORIES Glenmark Pharma S&P BSE HEALTHCARE
1-Day 0.10% -0.57% 1.18%
1-Month -12.39% 5.16% -0.75%
1-Year 31.31% 112.94% 61.82%
3-Year CAGR 10.39% 27.51% 18.16%
5-Year CAGR -5.47% 8.05% 19.79%

* Compound Annual Growth Rate

Here are more details on the ZIM LABORATORIES share price and the Glenmark Pharma share price.

Moving on to shareholding structures...

The promoters of ZIM LABORATORIES hold a 33.3% stake in the company. In case of Glenmark Pharma the stake stands at 46.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ZIM LABORATORIES and the shareholding pattern of Glenmark Pharma.

Finally, a word on dividends...

In the most recent financial year, ZIM LABORATORIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Glenmark Pharma paid Rs 2.5, and its dividend payout ratio stood at 18.7%.

You may visit here to review the dividend history of ZIM LABORATORIES, and the dividend history of Glenmark Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.